Multicenter phase II study of combination therapy with oral S-1 plus cisplatin in elderly patients with metastatic gastric cancer
- Conditions
- Elderly patients with metastatic gastric cancer
- Registration Number
- JPRN-UMIN000009349
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Not provided
1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma 2) Body temperature >= 38C 3) Severe mental disease 4) Current treatment with systemic steroids 5) Uncontrolled diabetes mellitus 6) Unstable angina pectoris within the past 3 weeks, or previous myocardial infarction within the past 6 months 7) Evidence of any other serious disease; renal failure, hepatic failure, interstitial pneumonia, or pulmonary fibrosis 8) Active bleeding 9) Massive ascites 10) Massive pleural effusion 11) Judged ineligible by the clinical investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Response rate, progression-free survival, time to treatment failure, adverse events